Perspectives on the etiology of chronic rhinosinusitis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 18, Issue 1, 2010, Pages 21-26

  Tan, Bruce K ^a   Schleimer, Robert P ^a   Kern, Robert C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acquired immunity; Barrier dysfunction; Epithelium; Inflammation; Innate immunity; Rhinosinusitis

Indexed keywords

CHEMOKINE; PATTERN RECOGNITION RECEPTOR; PROTEINASE ACTIVATED RECEPTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; ALTERNARIA; ASTHMA; ATOPIC DERMATITIS; HOST SUSCEPTIBILITY; HUMAN; IMMUNE DEFICIENCY; INFLAMMATORY DISEASE; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHINOSINUSITIS; STAPHYLOCOCCUS AUREUS;

ALTERNARIA; B-LYMPHOCYTES; CHRONIC DISEASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MUCOCILIARY CLEARANCE; MYCOSES; NASAL MUCOSA; RECEPTORS, PROTEINASE-ACTIVATED; RHINITIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 75749086479     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3283350053     Document Type: Review

References (71)

1. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004; 114:155-212.
2. Kern RC, Conley DB, Walsh W, et al. Perspectives on the etiology of chronic rhinosinusitis: an immune barrier hypothesis. Am J Rhinol 2008; 22:549-559.
3. Van Cauwenberge P, Van Hoecke H, Bachert C. Pathogenesis of chronic rhinosinusitis. Curr Allergy Asthma Rep 2006; 6:487-494.
4. Gillespie MB, Osguthorpe JD. Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis. Curr Allergy Asthma Rep 2004; 4:478-485.
5. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999; 74:877-884.
6. Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004; 114:1369-1375.
7. Sasama J, Sherris DA, Shin SH, et al. New paradigm for the roles of fungi and eosinophils in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2005; 13:2-8.
8. Ebbens FA, Fokkens WJ. The mold conundrum in chronic rhinosinusitis: where do we stand today? Curr Allergy Asthma Rep 2008; 8:93-101.
9. Rudack C, Steinhoff M, Mooren F, et al. PAR-2 activation regulates IL-8 and GRO-alpha synthesis by NF-kappaB, but not RANTES, IL-6, eotaxin or TARC expression in nasal epithelium. Clin Exp Allergy 2007; 37:1009-1022.
10. Ebbens FA, Georgalas C, Luiten S, et al. The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: a multicenter randomized controlled study. Laryngoscope 2009; 119:401-408.
11. Rank MA, Adolphson CR, Kita H. Antifungal therapy for chronic rhinosinusitis: the controversy persists. Curr Opin Allergy Clin Immunol 2009; 9:67-72.
12. Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 2001; 107:607-614.
13. Bachert C, Gevaert P, Zhang N, et al. Role of staphylococcal superantigens in airway disease. Chem Immunol Allergy 2007; 93:214-236.
14. Bachert C, Zhang N, van Zele T, et al. Staphylococcus aureus enterotoxins as immune stimulants in chronic rhinosinusitis. Clin Allergy Immunol 2007; 20:163-175.
15. Conley DB, Tripathi A, Seiberling KA, et al. Superantigens and chronic rhinosinusitis: skewing of T-cell receptor V beta-distributions in polyp-derived CD4p and CD8p T cells. Am J Rhinol 2006; 20:534-539.
16. Conley DB, Tripathi A, Seiberling KA, et al. Superantigens and chronic rhinosinusitis II: analysis of T-cell receptor V beta domains in nasal polyps. Am J Rhinol 2006; 20:451-455.
17. Patou J, Gevaert P, Van Zele T, et al. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. J Allergy Clin Immunol 2008; 121:110-115.
18. Seiberling KA, Conley DB, Tripathi A, et al. Superantigens and chronic rhinosinusitis: detection of staphylococcal exotoxins in nasal polyps. Laryngoscope 2005; 115:1580-1585.
19. Tripathi A, Conley DB, Grammer LC, et al. Immunoglobulin E to staphylococcal and streptococcal toxins in patients with chronic sinusitis/nasal polyposis. Laryngoscope 2004; 114:1822-1826.
20. Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol 2004; 114:981-983. (Pubitemid 39330280)
21. Van Zele T, Vaneechoutte M, Holtappels G, et al. Detection of enterotoxin DNA in Staphylococcus aureus strains obtained from the middle meatus in controls and nasal polyp patients. Am J Rhinol 2008; 22:223-227.
22. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193:172-179.
23. O'Regan GM, Irvine AD. The role of filaggrin loss-of-function mutations in atopic dermatitis. Curr Opin Allergy Clin Immunol 2008; 8:406-410.
24. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009; 124:3-20; quiz 21-22.
25. Swindle EJ, Collins JE, Davies DE. Breakdown in epithelial barrier function in patients with asthma: identification of novel therapeutic approaches. J Allergy Clin Immunol 2009; 124:23-34; quiz 35-126
26. Vroling AB, Fokkens WJ, van Drunen CM. How epithelial cells detect danger: aiding the immune response. Allergy 2008; 63:1110-1123.
27. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 2004; 4:978-988.
28. Zuckerman JD, Lee WY, DelGaudio JM, et al. Pathophysiology of nasal polyposis: the role of desmosomal junctions. Am J Rhinol 2008; 22:589-597.
29. Dejima K, Randell SH, Stutts MJ, et al. Potential role of abnormal ion transport in the pathogenesis of chronic sinusitis. Arch Otolaryngol Head Neck Surg 2006; 132:1352-1362.
30. Richer SL, Truong-Tran AQ, Conley DB, et al. Epithelial genes in chronic rhinosinusitis with and without nasal polyps. Am J Rhinol 2008; 22:228-234.
31. Descargues P, Deraison C, Bonnart C, et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005; 37:56-65.
32. Tieu DD, Kern RC, Schleimer RP. Alterations in epithelial barrier function and host defense responses in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124:37-42.
33. Shin SH, Lee YH, Jeon CH. Protease-dependent activation of nasal polyp epithelial cells by airborne fungi leads to migration of eosinophils and neutrophils. Acta Otolaryngol 2006; 126:1286-1294.
34. Kauffman HF, Tamm M, Timmerman JA, Borger P. House dust mite major allergens Der p 1 and Der p 5 activate human airway-derived epithelial cells by protease-dependent and protease-independent mechanisms. Clin Mol Allergy 2006; 4:5.
35. Briot A, Deraison C, Lacroix M, et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 2009; 206:1135-1147.
36. Avila PC, Schleimer RP. Airway epithelium. In: Kay AB, editor. Allergy and Allergic Diseases. New York: John Wiley & Sons; 2008. pp 366-397
37. Kim ST, Cha HE, Kim DY, et al. Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease. Acta Otolaryngol 2003; 123:81-85.
38. Lee HM, Kang HJ, Woo JS, et al. Upregulation of surfactant protein A in chronic rhinosinusitis. Laryngoscope 2006; 116:328-330.
39. Psaltis AJ, Bruhn MA, Ooi EH, et al. Nasal mucosa expression of lactoferrin in patients with chronic rhinosinusitis. Laryngoscope 2007; 117:2030-2035.
40. Meyer JE, Harder J, Sipos B, et al. Psoriasin (S100A7) is a principal antimicrobial peptide of the human tongue. Mucosal Immunol 2008; 1:239-243.
41. Eckert RL, Broome AM, Ruse M, et al. S100 proteins in the epidermis. J Invest Dermatol 2004; 123:23-33.
42. Sha Q, Truong-Tran AQ, Plitt JR, et al. Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 2004; 31:358-364.
43. Lane AP, Truong-Tran QA, Myers A, et al. Serum amyloid A, properdin, complement 3, and toll-like receptors are expressed locally in human sinonasal tissue. Am J Rhinol 2006; 20:117-123.
44. Claeys S, de Belder T, Holtappels G, et al. Human beta-defensins and toll-like receptors in the upper airway. Allergy 2003; 58:748-753.
45. Kato A, Schleimer RP. Beyond inflammation: airway epithelial cells are at the interface of innate and adaptive immunity. Curr Opin Immunol 2007; 19:711-720.
46. Dong Z, Yang Z, Wang C. Expression of TLR2 and TLR4 messenger RNA in the epithelial cells of the nasal airway. Am J Rhinol 2005; 19:236-239.
47. Claeys S, Van Hoecke H, Holtappels G, et al. Nasal polyps in patients with and without cystic fibrosis: a differentiation by innate markers and inflammatory mediators. Clin Exp Allergy 2005; 35:467-472.
48. Ramanathan M Jr, Lee WK, Dubin MG, et al. Sinonasal epithelial cell expression of toll-like receptor 9 is decreased in chronic rhinosinusitis with polyps. Am J Rhinol 2007; 21:110-116.
49. Lane AP, Truong-Tran QA, Schleimer RP. Altered expression of genes associated with innate immunity and inflammation in recalcitrant rhinosinusitis with polyps. Am J Rhinol 2006; 20:138-144.
50. Wolk K, Witte E, Wallace E, et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role inpsoriasis. Eur J Immunol2006;36:1309-1323.
51. Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity of tissues. Immunity 2004; 21:241-254.
52. Ramanathan M Jr, Spannhake EW, Lane AP. Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor. Laryngoscope 2007; 117:1839-1843.
53. Pickert G, Neufert C, Leppkes M, et al. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 2009; 206:1465-1472.
54. Aujla SJ, Kolls JK. IL-22: a critical mediator in mucosal host defense. J Mol Med 2009; 87:451-454.
55. Aujla SJ, Chan YR, Zheng M, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008; 14:275-281.
56. Schleimer RP, Kato A, Peters A, et al. Epithelium, inflammation, and immunity in the upper airways of humans: studies in chronic rhinosinusitis. Proc Am Thorac Soc 2009; 6:288-294.
57. Schleimer RP, Kato A, Kern R, et al. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol 2007; 120:1279-1284.
58. Hartmann E, Graefe H, Hopert A, et al. Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium. Clin Vaccine Immunol 2006; 13:1278-1286.
59. Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3-and Th2 cytokinedependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007; 179:1080-1087.
60. Liu YJ. TSLP in epithelial cell and dendritic cell cross talk. Adv Immunol 2009; 101:1-25.
61. Wise SK, Ahn CN, Schlosser RJ. Localized immunoglobulin E expression in allergic rhinitis and nasal polyposis. Curr Opin Otolaryngol Head Neck Surg 2009; 17:216-222.
62. Kato A, Peters A, Suh L, et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol 2008; 121:1385-1392.
63. Kato A, Xiao H, Chustz RT, et al. Local release of B cell-activating factor of the TNF family after segmental allergen challenge of allergic subjects. J Allergy Clin Immunol 2009; 123:369-375.
64. Kato A, Truong-Tran AQ, Scott AL, et al. Airway epithelial cells produce B cellactivating factor of TNF family by an IFN-beta-dependent mechanism. J Immunol 2006; 177:7164-7172.
65. Castigli E, Wilson SA, Scott S, et al. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 2005; 201:35-39.
66. Pleass RJ, Lang ML, Kerr MA, Woof JM. IgA is a more potent inducer of NADPH oxidase activation and degranulation in blood eosinophils than IgE. Mol Immunol 2007; 44:1401-1408.
67. Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 2008; 122:961-968.
68. Van Bruaene N, Perez-Novo CA, Basinski TM, et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 2008; 121:1435-1441; 1441 e1431-1433.
69. Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese. J Allergy Clin Immunol 2009; 124:478-484.
70. Basinski TM, Holzmann D, Eiwegger T, et al. Dual nature of T cell-epithelium interaction in chronic rhinosinusitis. J Allergy Clin Immunol 2009; 124:74-80.
71. Schadt EE. Molecular networks as sensors and drivers of common human diseases. Nature 2009; 461:218-223.